Clinuvel Pharmaceuticals is a Melbourne-based specialty pharmaceutical company focused on treatments for skin and light-related disorders. Its main product is afamelanotide, a melanocortin analogue given as a small implant under the skin to help people with a rare inherited condition that causes severe pain on exposure to sunlight. Clinuvel supplies the medicine to specialist clinics and patients in approved markets, and it also studies related uses of its drug in other skin and pigmentation conditions.
The shares are listed on the Australian Securities Exchange in Australia under the code CUV, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #855 of 1815 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendWeak
42/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-22.2%
From 52-week high-42.8%
MomentumWeak
37/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-23.4%
6-month return-14.1%
12-month, skipping last month-28.2%
Stability (higher is calmer)Strong
71/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)41.9%
Worst drawdown, 1 year (smaller is calmer)-44.3%
LiquidityStrong
81/100
Trades actively.
See the numbers →
Avg daily value traded1.19M AUD
Zero-volume days0.0%
IncomeWeak
27/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.7%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 7.080 – 13.399Daily closes, split-adjusted
Signals
50-day average8.597
200-day average9.666
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.315
Technical summary
Daily
Strongly bearish
1 bullish · 3 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
7.80
Bearish
EMA 10
7.75
Bearish
SMA 20
8.03
Bearish
EMA 20
7.96
Bearish
SMA 50
8.60
Bearish
EMA 50
8.43
Bearish
SMA 100
9.14
Bearish
EMA 100
8.91
Bearish
SMA 200
9.67
Bearish
EMA 200
9.55
Bearish
Oscillators (daily)
RSI (14)
36.63
Neutral
MACD (12, 26)
-0.27
Bearish
Momentum (12)
-8.85
Bearish
Stochastic %K (14)
28.95
Neutral
Williams %R (14)
-71.05
Neutral
CCI (20)
-126.0
Bullish
Pivot points (classic, last session)
S3
7.26
S2
7.37
S1
7.45
Pivot
7.56
R1
7.64
R2
7.75
R3
7.83
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.05 AUD
Yield on today's price
0.66%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
3 Sep 2026
0.0500
4 Sep 2025
0.0500
5 Sep 2024
0.0500
5 Sep 2023
0.0500
6 Sep 2022
0.0400
2 Sep 2021
0.0250
3 Sep 2020
0.0250
4 Sep 2019
0.0250
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
